Browsing by Author Gil-Martín, Marta
Showing results 1 to 7 of 7
| Issue Date | Title | Author(s) |
|---|---|---|
| 18-Sep-2018 | A phase I trial of oncolytic adenovirus ICOVIR-5 administered intravenously to cutaneous and uveal melanoma patients | García Martin, Margarita; Moreno Olié, Rafael; Gil-Martín, Marta; Cascallò, Manel; Ochoa de Olza, Maria; Cuadra, Carmen; Piulats, Josep M.; Navarro-Pérez, Valentin; Domenech, Marta; Alemany Bonastre, Ramon; Salazar Soler, Ramón |
| 10-Nov-2019 | Niraparib Maintenance Therapy in Patients With Recurrent Ovarian Cancer After a Partial Response to the Last Platinum-Based Chemotherapy in the ENGOT-OV16/NOVA Trial | Del Campo, Josep M.; Matulonis, Ursula A.; Malander, Susanne; Provencher, Diane; Mahner, Sven; Follana, Philippe; Waters, Justin; Berek, Jonathan S.; Woie, Kathrine; Oza, Amit M.; Canzler, Ulrich; Gil-Martín, Marta; Lesoin, Anne; Monk, Bradley J.; Lund, Bente; Gilbert, Lucy; Wenham, Robert M.; Benigno, Benedict; Arora, Sujata; Hazard, Sebastien J.; Mirza, Mansoor R. |
| 1-Dec-2019 | Niraparib maintenance treatment improves time without symptoms or toxicity (TWiST) versus routine surveillance in recurrent ovarian cancer: a TWiST analysis of the ENGOT-OV16/NOVA trial | Matulonis, Ursula A.; Walder, Lydia; Nøttrup, Trine J.; Bessette, Paul; Mahner, Sven; Gil-Martín, Marta; Kalbacher, Elsa; Ledermann, Jonathan A.; Wenham, Robert M.; Woie, Kathrine; Lau, Susie; Marmé, Frederik; Casado Herraez, Antonio; Hardy-Bessard, Anne-Claire; Banerjee, Susana N.; Lindahl, Gabriel; Benigno, Benedict; Buscema, Joseph; Travers, Karin; Guy, Holly; Mirza, Mansoor R. |
| 1-Jan-2018 | Phosphatidylinositol 3-Kinase -Selective Inhibition With Alpelisib (BYL719) in PIK3CA-Altered Solid Tumors: Results From the First-in-Human Study | Juric, Dejan; Rodon, Jordi; Tabernero Caturla, Josep; Janku, Filip; Burris, Howard A.; Schellens, Jan H. M.; Middleton, Mark R.; Berlin, Jordan; Schuler, Martin; Gil-Martín, Marta; Rugo, Hope S.; Seggewiss Bernhardt, Ruth; Huang, Alan; Bootle, Douglas; Demanse, David; Blumenstein, Lars; Coughlin, Christina; Quadt, Cornelia; Baselga Torres, Josep, 1959- |
| 1-Dec-2014 | Selective activity over a constitutively active RET-variant of the oral multikinase inhibitor dovitinib: results of the CNIO-BR002 phase I-trial | Quintela Fandino, Miguel; Bueno, María José; Lombardia, Luis; Gil-Martín, Marta; González-Martin, Antonio; Marquez, Raul; Bratos, Raquel; Guerra, Juan; Tan, Eugene; Lopez, Antonio; Colomer Bosch, Ramón; Salazar Soler, Ramón |
| 30-Jul-2017 | TGFβ controls ovarian cancer cell proliferation | Alsina Sanchís, Elisenda; Figueras i Amat, Agnès; Lahiguera, Álvaro; Gil-Martín, Marta; Pardo, Beatriz; Piulats, Josep M.; Martí, Lola; Ponce i Sebastià, Jordi; Matias-Guiu, Xavier; Vidal-Bel, August; Villanueva Garatachea, Alberto; Viñals Canals, Francesc |
| 1-Aug-2019 | Trastuzumab duocarmazine in locally advanced and metastatic solid tumours and HER2-expressing breast cancer: a phase 1 dose-escalation and dose-expansion study | Banerji, Udai; van Herpen, Carla M. L.; Saura, Cristina; Thistiethwaite, Fiona; Lord, Simon; Moreno Aguado, Víctor; Macpherson, Iain R.; Boni, Valentina; Rolfo, Christian; Vries Ege, Elisabeth G. E. de; Rottey, Sylvie; Geenen, Jill; Eskens, Ferry; Gil-Martín, Marta; Mommers, Ellen C.; Koper, Norbert P.; Aftimos, Philippe |